Summary
Aims of the study We know little about the level of physical activity, respiratory physiotherapy practices, and nutritional status of people with primary ciliary dyskinesia (PCD), although these are important aspects of patients with chronic respiratory disease. We assessed physical activity, respiratory physiotherapy practices, and nutritional status among people with PCD in Switzerland, investigated how these vary by age, and identified factors associated with regular physical activity.
Methods We sent a postal questionnaire survey to people with PCD enrolled in the Swiss PCD registry (CH-PCD), based on the standardised FOLLOW-PCD patient questionnaire. We collected information about physical activity, physiotherapy, respiratory symptoms, and nutritional status. We calculated the metabolic equivalent (MET) to better reflect the intensity of the reported physical activities. To assess nutritional status, we extracted information from CH-PCD and calculated participants’ body mass index (BMI).
Results Of the 86 questionnaires we sent, 74 (86% response rate) were returned from 24 children and 50 adults. The median age at survey completion was 23 years [IQR (interquartile range) 15–51], and 51% were female. Among all 74 participants, 48 (65%) performed sports regularly. Children were vigorously active (median MET 9.1; IQR 7.9–9.6) and adults were moderately active (median MET 5.5; IQR 4.3-6.9). 59 participants (80%) reported performing some type of respiratory physiotherapy. However, only 30% of adults saw a professional physiotherapist compared with 75% of children. Half of the participants had normal BMI; one child (4%) and two adults (4%) were underweight. People who were regularly physically active reported seeing a physiotherapist more often.
Conclusions Our study is the first to provide patient-reported data about physical activity, respiratory physiotherapy, and nutrition among people with PCD. Our results highlight that professional respiratory physiotherapy, exercise recommendations, and nutritional advice are often not implemented in the care of people with PCD in Switzerland. Multidisciplinary care in specialised centres by teams including physiotherapists and nutrition consultants could improve the quality of life of people with PCD.
Competing Interest Statement
This study is funded by a Swiss National Science Foundation Ambizione fellowship (PZ00P3_185923) and by a Swiss National Science Foundation project grant (320030B_192804). PCD research at the Institute of Social and Preventive Medicine (ISPM) at the University of Bern also receives funding by the Lung League Bern. The authors participate in the BEAT-PCD (Better experimental approaches to treat PCD) clinical research collaboration, supported by the European Respiratory Society, and they are supporting members of the PCD core of ERN-LUNG (European Reference Network on rare respiratory diseases). FN Belle is supported by Swiss Cancer Research (KFS-4722-02-2019). C Clarenbach received advisory fees from Roche, Novartis, Boehringer, GSK, Astra Zeneca, Sanofi, Vifor, OM Pharma, CSL Behring, Grifols, Daiichi Sankyo and Mundipharma within the last 36 months. P Latzin received grants, honorary, for participation in data safety monitoring board or advisory board from Vertex, Vifor, OM Pharma, Polyphor, Santhera, Sanofi Aventis within the last 36 months.
Funding Statement
This study is funded by a Swiss National Science Foundation Ambizione fellowship (PZ00P3_185923) and by a Swiss National Science Foundation project grant (320030B_192804). PCD research at the Institute of Social and Preventive Medicine (ISPM) at the University of Bern also receives funding by the Lung League Bern.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Cantonal Ethics Committee of Bern in 2015 (KEK-BE: 060/2015)
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* group members listed in acknowledgments
Data Availability
Data may be shared upon reasonable request.
